Apoquel® (oclacitinib tablet) is #1 in veterinarian and pet owner satisfaction1*

"Apoquel is a reliable, fast-acting way to ensure the pet finds relief from [allergic] itching."

— Dr. Holly Dutton

North Bay Animal Hospital, Florida

"Apoquel works well to provide relief, increasing owners' confidence in our recommendation and building trust that we are going to help their pets."

— Dr. Samantha Lockwood
Dermatology for Animals, Arizona

"Whenever you solve a problem for a pet owner, it always results in increased trust and more acceptance of other recommendations."

— Dr. Farid Saleh
Erlich Animal Hospital, Florida

*Based on survey data from veterinarians (n=250) and pet owners (n=150).

success-satisfaction-map success-satisfaction-map success-satisfaction-map

Apoquel has impacted veterinarians, pets and their owners across the US with the United States of Apoquel

Hear from your peers about why Apoquel is their first choice for allergic itch relief

See the impact Apoquel can have in your practice

Benefits of Apoquel

Changing the course of allergic itch treatment

Pet owner success & satisfaction

Pet owners are highly satisfied with Apoquel treatment for their dogs3

90%

would recommend Apoquel to a friend

98%

believed Apoquel improved the quality of their dog’s life

96%

said Apoquel improved the quality of their own life

Apoquel has changed the lives of dogs and their owners4

Bijou used Apoquel as first-line treatment

Nani suffered from a grass allergy

Gunner has itch and an infected hot spot

Captain did not do well on steroids

You may also be interested in

References: 1. Data on file, Apoquel®/Cytopoint® Vet Tracker Wave 11, 2018, Zoetis Inc. 2. Data on file, Apoquel®/Cytopoint® Vet Tracker, Wave 6, 2019, Zoetis Inc. 3. Data on file, Apoquel Early Experience Program Pet Owner Aggregate Data, 2014, Zoetis Inc. 4. Data on file, Pet Owner Case Studies-Bijou, Nani, Gunner, Captain and Molly, Zoetis Inc.

Apoquel Indications

Control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age.

Apoquel Important Safety Information

Do not use Apoquel in dogs less than 12 months of age or those with serious infections. Apoquel may increase the chances of developing serious infections, and may cause existing parasitic skin infestations or pre-existing cancers to get worse. Consider the risks and benefits of treatment in dogs with a history of recurrence of these conditions. New neoplastic conditions (benign and malignant) were observed in clinical studies and post-approval. Apoquel has not been tested in dogs receiving some medications including some commonly used to treat skin conditions such as corticosteroids and cyclosporines. Do not use in breeding, pregnant, or lactating dogs. Most common side effects are vomiting and diarrhea. Apoquel has been used safely with many common medications including parasiticides, antibiotics and vaccines.

For more information, please see the full Prescribing Information.

Apoquel Indications

Control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age.

Apoquel Important Safety Information

Do not use Apoquel in dogs less than 12 months of age or those with serious infections. Apoquel may increase the chances of developing serious infections, and may cause existing parasitic skin infestations or pre-existing cancers to get worse. Consider the risks and benefits of treatment in dogs with a history of recurrence of these conditions. New neoplastic conditions (benign and malignant) were observed in clinical studies and post-approval. Apoquel has not been tested in dogs receiving some medications including some commonly used to treat skin conditions such as corticosteroids and cyclosporines. Do not use in breeding, pregnant, or lactating dogs. Most common side effects are vomiting and diarrhea. Apoquel has been used safely with many common medications including parasiticides, antibiotics and vaccines.

For more information, please see the full Prescribing Information.